Facebook Pixel Code

Phaarmasia Share Price

NSE
BSE

PHAARMASIA

Sector : Pharmaceuticals and health care | Smallcap | BSE

Here's the live share price of Phaarmasia along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹119.45
-1.97₹ -2.40
As on Jan 16, 2026, 10:42 AM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Phaarmasia Price Performance

Today's LowToday's High
₹119.45₹119.45
₹119.45
52 Weeks' Low52 Weeks' High
₹23.60₹131.75
₹119.45
Open Price
₹119.45
Prev. Close
₹121.85
Volume
107

Over the last 5 years, the share price of Phaarmasia has gained 29.38% CAGR. Over the past year, the corresponding return has been 163.16%.

Phaarmasia’s current P/E of 104.32x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.

Phaarmasia Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Phaarmasia
-3.8329.05272.63241.32168.4565.7729.90
Sun Pharmaceutical Industries
-4.85-6.751.32-3.00-4.6017.4222.65
Divi's Laboratories
-4.21-0.45-3.86-6.937.5023.8111.67
Torrent Pharmaceuticals
-0.765.6513.0916.1324.2836.5324.11
Cipla
-5.35-8.28-11.27-7.28-4.469.3410.96
Lupin
0.895.7313.8813.253.8542.8715.09
Dr. Reddy's Laboratories
-1.66-7.26-3.66-5.85-11.3411.122.66
Mankind Pharma
-1.373.86-9.00-16.08-14.2416.059.34
Zydus Lifesciences
-2.86-4.30-9.79-8.84-10.4726.1912.57
Alkem Laboratories
0.894.134.9318.5412.4424.3913.52
Aurobindo Pharma
-1.720.046.922.953.3738.454.81
Abbott India
-1.61-0.06-6.39-18.780.418.1513.20
Laurus Labs
-1.967.4623.2730.4993.8044.9723.89
Biocon
0.83-2.427.01-2.33-0.3415.04-3.54
Glenmark Pharmaceuticals
-3.630.885.79-10.0735.6068.3231.35
GlaxoSmithKline Pharmaceuticals
-1.99-8.70-14.09-26.5315.0621.769.17
Ipca Laboratories
-2.594.2715.462.23-3.9920.107.32
Anthem Biosciences
-3.67-11.12-19.92-14.95-14.95-5.26-3.19
Ajanta Pharma
-5.281.7411.45-0.57-6.7531.7018.18
J B Chemicals & Pharmaceuticals
-0.875.6313.6214.637.2624.8829.44

Over the last one year, Phaarmasia has gained 168.45% compared to peers like Sun Pharmaceutical Industries (-4.60%), Divi's Laboratories (7.50%), Torrent Pharmaceuticals (24.28%). From a 5 year perspective, Phaarmasia has outperformed peers relative to Sun Pharmaceutical Industries (22.65%) and Divi's Laboratories (11.67%).

Phaarmasia Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Phaarmasia Stock Technicals

Moving Average

DaySMAEMA
5125.74123.87
10122.64121.34
20114.19112.91
5081.0689.52
10057.6469.46
20044.1855.2

Phaarmasia Share Holding Pattern

In the latest quarter, Phaarmasia remained same as its previous close in promoter holding, while DII stake unchanged at 0.05%, FII holding unchanged at 0.00%, and public shareholding moved up to 26.44% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Phaarmasia Corporate Actions

Date Time
Announcement
Nov 15, 2025, 12:22 AM ISTPhaarmasia Ltd. - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025
Nov 15, 2025, 12:16 AM ISTPhaarmasia Ltd. - Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2025
Nov 14, 2025, 11:55 PM ISTPhaarmasia Ltd. - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 14Th November, 2025 To Approve The Unaud
Nov 07, 2025, 9:21 PM ISTPhaarmasia Ltd. - Board Meeting Intimation for Notice Of 05Th Board Meeting Of Phaarmasia Limited Scheduled To Be Held On Fri
Oct 18, 2025, 9:51 PM ISTPhaarmasia Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

About Phaarmasia

Phaarmasia Ltd. is a Public Limited Listed company incorporated on 06/02/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1981PLC002915 and registration number is 002915. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 24.37 Cr. and Equity Capital is Rs. 6.83 Cr. for the Year ended 31/03/2025.

Management

  • Mr. Maneesh Ramakant Sapte
    Non Executive Director
  • Mr. Naga Bhaskara Rao Yallapragada
    Whole Time Director
  • Mr. Vinay Ramakant Sapte
    Non Executive Director
  • Mrs. Rashmi Vinay Sapte
    Non Executive Director
  • Mr. Pravin Mohandas Hegde
    Independent Director
  • Mr. Ajit Gopal Jamkhandikar
    Independent Director

FAQs on Phaarmasia Share Price

What is the share price of Phaarmasia?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Phaarmasia is ₹119.45 as on Jan 16, 2026.

What kind of stock is Phaarmasia?

The Phaarmasia is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.

What is the Market Cap of Phaarmasia?

The market cap of Phaarmasia is ₹81.55 Cr as on Jan 16, 2026.

What are today's High and Low prices of Phaarmasia?

Today’s highest and lowest price of Phaarmasia are ₹119.45 and ₹119.45.

What are the 52 Week High and 52 Week Low of Phaarmasia?

The 52-week high/low is the highest and lowest price at which Phaarmasia stock has traded in the past 52-week or nearly a year. The 52-week high of Phaarmasia is ₹131.75 and 52-week low of Phaarmasia is ₹23.60 as on Jan 16, 2026.

How has the Phaarmasia performed historically in terms of returns?

The Phaarmasia has shown returns of -1.97% over the past day, 26.51% for the past month, 265.29% over 3 months, 163.16% over 1 year, 64.67% across 3 years, and 29.38% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Phaarmasia?

P/E ratio of and PB ratio of Phaarmasia are 104.32 and 7.59 on Jan 16, 2026. While the company gives a dividend yield of 0.00 per annum.

Phaarmasia News

icon
Market Pulse